Nuo Therapeutics AURX
OTC AURX
$1.30 +0.01 (+0.78%)
As of: Oct 23, 2026 · 9:44 AM EDT

Nuo Therapeutics (AURX) Asset Writedowns and Impairment (2014 - 2025)

Updated

Nuo Therapeutics (AURX) reported Asset Writedowns and Impairment of $10,252 for Q4 2025.

Analysis

Nuo Therapeutics (AURX) Asset Writedowns and Impairment (2014 - 2025) Analysis & Trends

For FY2025, Nuo Therapeutics posted Asset Writedowns and Impairment of $19,371, down 35.4% from FY2024.

  • By year, Asset Writedowns and Impairment came in at $30,000 in FY2024 (+86.6%) and $16,074 in FY2023.
  • The Q4 2025 figure ranks as the highest quarterly Asset Writedowns and Impairment since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.17 Bn 228.32 Bn 4.88 Bn
2 Abbott Laboratories 179.42 Bn 150.51 Bn 7.27 Bn
3 Danaher 161.98 Bn 145.80 Bn 3.61 Bn
4 Intuitive Surgical 156.76 Bn 137.18 Bn 2.08 Bn
5 Medtronic 122.13 Bn 88.00 Bn 6.34 Bn
6 Stryker 117.84 Bn 103.96 Bn 4.50 Bn
7 Boston Scientific 66.19 Bn 61.20 Bn 3.85 Bn
8 Becton Dickinson 54.16 Bn 51.31 Bn 2.32 Bn
9 Edwards Lifesciences 51.35 Bn 35.47 Bn 1.35 Bn
10 Nuo Therapeutics 62.96 Mn 61.13 Mn 1.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 10,252.00
Mar 31, 2025 9,119.00
Sep 30, 2024 30,000.00
Jun 30, 2019 14,000.00
Dec 31, 2018 9,098.00
Sep 30, 2018 5,515.00
Mar 31, 2018 949.00
Dec 31, 2017 7.22 Mn
Mar 31, 2017 915.00
Dec 31, 2015 3.31 Mn
Sep 30, 2015 23.74 Mn
Mar 31, 2015 13,240.00
Jun 30, 2014 4.68 Mn
API Access

Nuo Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=AURX&period=max&api_key=YOUR_API_KEY